Related Experiment Video

Updated: Jul 19, 2026

Intravenous Endotoxin Challenge in Healthy Humans: An Experimental Platform to Investigate and Modulate Systemic Inflammation
07:48

Intravenous Endotoxin Challenge in Healthy Humans: An Experimental Platform to Investigate and Modulate Systemic Inflammation

Published on: May 16, 2016

Comment on: Human intravenous immunoglobulin for experimental streptococcal toxic shock: bacterial clearance and

Govindarajan Rajagopalan, Robin Patel, Srini V Kaveri

    The Journal of Antimicrobial Chemotherapy
    |October 31, 2006
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation
    10:35

    Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation

    Published on: December 26, 2017

    Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety
    06:37

    Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety

    Published on: September 15, 2023

    Related Experiment Videos

    Last Updated: Jul 19, 2026

    Intravenous Endotoxin Challenge in Healthy Humans: An Experimental Platform to Investigate and Modulate Systemic Inflammation
    07:48

    Intravenous Endotoxin Challenge in Healthy Humans: An Experimental Platform to Investigate and Modulate Systemic Inflammation

    Published on: May 16, 2016

    Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation
    10:35

    Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation

    Published on: December 26, 2017

    Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety
    06:37

    Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety

    Published on: September 15, 2023

    Related Concept Videos

    Acute Inflammation III: Local and Systemic Effects01:25

    Acute Inflammation III: Local and Systemic Effects

    Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...

    Articles linked to this work by shared authors, journal, and citation graph.

    Staphylococcus aureus superantigens drive a concentration-dependent neutrophilic or eosinophilic pulmonary inflammation in mouse models of cystic fibrosis.

    Journal of immunology (Baltimore, Md. : 1950)·2026

    Epidermal growth factor receptor regulates Beclin-1 in hyperoxic acute lung injury.

    BMJ open respiratory research·2026

    Prevalence and production of superantigen exotoxins by cystic fibrosis Staphylococcus aureus isolates.

    Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2025

    From pain relief to organ protection: epidural analgesia in acute pancreatitis-a narrative review of its evolving role.

    Clinical journal of gastroenterology·2025

    Prevalence, Production and the Role of Staphylococcus aureus Superantigens in Cystic Fibrosis Lung Disease.

    bioRxiv : the preprint server for biology·2025

    Epidermal Growth Factor Receptor Regulates Beclin-1 in Hyperoxic Acute Lung Injury.

    bioRxiv : the preprint server for biology·2025

    Oxazolidinones in the Clinical Management of Staphylococcal Infection-Linezolid or Tedizolid? A review on behalf of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Staphylococci and Staphylococcal Diseases (ESGS).

    The Journal of antimicrobial chemotherapy·2026

    Phylogenetic diversification of the PoxtA ribosomal protection determinant.

    The Journal of antimicrobial chemotherapy·2026

    Intergeneric mobilization of a genomic island mediated by a helper integrative conjugative element from Streptococcus suis to Enterococcus faecalis.

    The Journal of antimicrobial chemotherapy·2026

    Efficacy and safety of switching to once-daily oral doravirine plus raltegravir in virologically suppressed people with HIV-1: a randomized, open-label, multicentre phase 2 study (DORAL).

    The Journal of antimicrobial chemotherapy·2026

    Beyond susceptibility: pharmacokinetic and pharmacodynamic constraints of existing oral antibiotics in extensively drug-resistant typhoid fever.

    The Journal of antimicrobial chemotherapy·2026

    Tigecycline displays bactericidal activity against multidrug-resistant Neisseria gonorrhoeae and enhances clearance from a mouse infection model.

    The Journal of antimicrobial chemotherapy·2026

    X-linked hyper IgM syndrome with a novel CD40-ligand gene mutation suffered from infection of Talaromyces marneffei.

    Frontiers in immunology·2026

    Intravitreal Anti-vascular Endothelial Growth Factor Injection Practices Among Indonesian Vitreoretinal Specialists: Findings From a 2021 National Survey.

    Cureus·2026

    A narrative review of barrier-matched engineering of macrophages for solid tumor immunotherapy: design logic, translational barriers and clinical outlook.

    Translational cancer research·2026

    Comparison of the efficacy of TXNDC5 monoclonal antibody versus conventional drugs in the treatment of intestinal fibrosis associated with inflammatory bowel disease.

    Journal of molecular histology·2026

    Tumor-targeted IL-10 synergizes with IL-2 to enhance antitumor immunity while minimizing immune-related adverse events.

    Nature communications·2026

    When Should Ileal Pouch-Anal Anastomosis Be Performed After Inpatient Total Abdominal Colectomy for Acute Medically Refractory Ulcerative Colitis? Experience of 274 Consecutive Patients.

    Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us